The struggling biotech firm, NovaGen Therapeutics, faced severe monetary difficulties stemming from failed clinical trials and mounting debt. Their internal management lacked the experience to manage the https://nicoleqadn220650.mpeblog.com/74361893/biotech-cfo-services-a-case-study-in-fiscal-restructuring